Efficacy of Statins Among Major Depressive Disorder

Conditions studied

Major Depressive Disorder, MDD

About this study

The goal of this clinical trial is to learn if drug Rosuvastatin 10 mg works to treat MDD in adults. It will also learn about the safety of Rosuvastatin 10 mg .The main questions it aims to answer are: Does Rusovastatin lower the score of The Montgomery Asberg Depression Rating Scale (MADRS) among adult participants with Major Depression Disorder ( MDD )? What medical problems do participants have when taking drug ABC? Participants will: Take Rosuvastatin 10 mg every day for 3 months Visit the clinic once every 4 weeks for checkups and tests Report any side effects for Rosuvastatin 10 mg and reassess the severity of depression using The Montgomery Asberg Depression Rating Scale (MADRS)

Interventions

• Drug: Rosuvastatin 10 mg tablet. — The dose of rosuvastatin was derived from literature describing the doses at which the agents' targeted actions are effective and safe. The 10- mg rosuvastatin dose reflects the lowest prescribed therapeutic dose A serum cholesterol level will be drawn from the whole participants and sent to the central laboratories of El-Demerdash hospital at baseline and at week 12. At each visit, participants will be requested to return all unused investigational products. Adherence to medication will be assessed by a pill count.
• Drug: Sertraline Pill — Both control and intervention group will receive the sertraline as a standard therapy

Primary outcomes

• Severity of depression among Participants with MDD as Assessed by MADRS scale (3 months (12 weeks))

Eligibility information

Study locations

• El demerdash hospital, Cairo, Al Abbasia +02 Egypt